MedPath

Clinical Trial to Evaluate the Safety and Efficacy of AGR Tablet as a Treatment of Perennial Allergic Rhinitis in Korean

Phase 3
Completed
Conditions
Perennial Allergic Rhinitis
Allergic Rhinitis
Non-seasonal Allergic Rhinitis
Interventions
Drug: AGR tablet
Drug: Placebo (for AGR tablet and/or Active Comparator)
Drug: Active Comparator
Registration Number
NCT01982916
Lead Sponsor
Ahn-Gook Pharmaceuticals Co.,Ltd
Brief Summary

The purpose of this study is to evaluate treatment of perennial allergic rhinitis in Korean patients with AGR tablet.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
324
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AGR & PlaceboAGR tabletAGR tablet by qd and Placebo by bid for 4 weeks
AGR & PlaceboPlacebo (for AGR tablet and/or Active Comparator)AGR tablet by qd and Placebo by bid for 4 weeks
Active comparatorPlacebo (for AGR tablet and/or Active Comparator)Active Comparator and Placebo by bid for 4 weeks
Active comparatorActive ComparatorActive Comparator and Placebo by bid for 4 weeks
PlaceboPlacebo (for AGR tablet and/or Active Comparator)Placebo by bid for 4 weeks
Primary Outcome Measures
NameTimeMethod
Change of 4NTSS(4 Nasal Total Symptoms score) from baseline4 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (9)

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul National University Bundang Hospital

🇰🇷

Seongnam, Gyeonggi-do, Korea, Republic of

Inha University Hospital

🇰🇷

Incheon, Korea, Republic of

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Kyung Hee University Medical Center

🇰🇷

Seoul, Korea, Republic of

Severance Hospital

🇰🇷

Seoul, Korea, Republic of

Seoul St. Mary's Hospital

🇰🇷

Seoul, Korea, Republic of

Konkuk University Medical Center

🇰🇷

Seoul, Korea, Republic of

SMG-SNU Boramae Medical Center

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath